Pharma Major Lupin’s US subsidiary, Lupin Pharmaceuticals Inc has launched the authorized generic for G.D. Searle LLC’s (a subsidiary of Pfizer Inc)’ Celebrex Capsules (Celebrex) , which are available in 50 mg, 100 mg, 200 mg and 400 mg strengths. Lupin had earlier signed a licensing agreement with Pfizer Inc for Celebrex.
Celebrex Capsules had annual U.S sales of $ 2.54 billion, according to IMS MAT September, 2014.
Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded and generic formulations as well as biotechnology products and APIs globally. The Company is a significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, CNS, GI, Anti-Infective and NSAID space and holds global leadership positions in the Anti-TB and Cephalosporin segment.
